374 related articles for article (PubMed ID: 25749719)
21. Epigenetic control of hematopoiesis: the PU.1 chromatin connection.
van Riel B; Rosenbauer F
Biol Chem; 2014 Nov; 395(11):1265-74. PubMed ID: 25205721
[TBL] [Abstract][Full Text] [Related]
22. RUNX1 regulates corepressor interactions of PU.1.
Hu Z; Gu X; Baraoidan K; Ibanez V; Sharma A; Kadkol S; Munker R; Ackerman S; Nucifora G; Saunthararajah Y
Blood; 2011 Jun; 117(24):6498-508. PubMed ID: 21518930
[TBL] [Abstract][Full Text] [Related]
23. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
[TBL] [Abstract][Full Text] [Related]
24. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
25. AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis.
Kurokawa M
Int J Hematol; 2006 Aug; 84(2):136-42. PubMed ID: 16926135
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development.
Rothenberg EV; Hosokawa H; Ungerbäck J
Front Immunol; 2019; 10():228. PubMed ID: 30842770
[TBL] [Abstract][Full Text] [Related]
27. The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells.
Staber PB; Zhang P; Ye M; Welner RS; Levantini E; Di Ruscio A; Ebralidze AK; Bach C; Zhang H; Zhang J; Vanura K; Delwel R; Yang H; Huang G; Tenen DG
Blood; 2014 Oct; 124(15):2391-9. PubMed ID: 25185713
[TBL] [Abstract][Full Text] [Related]
28. Cell-type-specific activation and repression of PU.1 by a complex of discrete, functionally specialized cis-regulatory elements.
Zarnegar MA; Chen J; Rothenberg EV
Mol Cell Biol; 2010 Oct; 30(20):4922-39. PubMed ID: 20696839
[TBL] [Abstract][Full Text] [Related]
29. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
Peterson LF; Lo MC; Okumura AJ; Zhang DE
Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
[TBL] [Abstract][Full Text] [Related]
30. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
31. Increased dosage of the RUNX1/AML1 gene: a third mode of RUNX leukemia?
Osato M; Ito Y
Crit Rev Eukaryot Gene Expr; 2005; 15(3):217-28. PubMed ID: 16390318
[TBL] [Abstract][Full Text] [Related]
32. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
33. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.
Ganly P; Walker LC; Morris CM
Leuk Lymphoma; 2004 Jan; 45(1):1-10. PubMed ID: 15061191
[TBL] [Abstract][Full Text] [Related]
34. Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation.
Willcockson MA; Taylor SJ; Ghosh S; Healton SE; Wheat JC; Wilson TJ; Steidl U; Skoultchi AI
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17841-17847. PubMed ID: 31431533
[TBL] [Abstract][Full Text] [Related]
35. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
[TBL] [Abstract][Full Text] [Related]
36. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
37. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
[TBL] [Abstract][Full Text] [Related]
38. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
Dahl R; Simon MC
Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
[TBL] [Abstract][Full Text] [Related]
39. RUNX1: A microRNA hub in normal and malignant hematopoiesis.
Rossetti S; Sacchi N
Int J Mol Sci; 2013 Jan; 14(1):1566-88. PubMed ID: 23344057
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
